Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets

被引:8
|
作者
Belew, Sileshi [1 ,2 ,3 ]
Suleman, Sultan [1 ,2 ]
Duguma, Markos [1 ,2 ]
Teshome, Henok [1 ,2 ]
Wynendaele, Evelien [3 ]
Duchateau, Luc [4 ]
De Spiegeleer, Bart [3 ]
机构
[1] Jimma Univ, Lab Drug Qual JuLaDQ, POB 378, Jimma, Ethiopia
[2] Jimma Univ, Sch Pharm, POB 378, Jimma, Ethiopia
[3] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
[4] Univ Ghent, Fac Vet Med, Biometr Res Grp, Salisburylaan 133, B-9820 Merelbeke, Belgium
关键词
Artemether; Dissolution; In-vitro; Lumefantrine; PHYSICOCHEMICAL PROPERTIES; FALCIPARUM-MALARIA; CLASSIFICATION; SOLUBILITY; SURFACTANT; PROFILES; DRUGS;
D O I
10.1186/s12936-020-03209-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Dissolution of artemether (ART) and lumefantrine (LUM) active pharmaceutical ingredients (APIs) in fixed dose combination (FDC) ART/LUM tablets is one of the critical quality attributes. Thus, the verification of the release profile of ART and LUM from FDC ART/LUM tablets using a robust and discriminatory dissolution method is crucial. Therefore, the aim of this study was to develop and validate an appropriate dissolution method for quality control of FDC ART/LUM tablets. Methods The dissolution medium was selected based on saturation solubility data and sink conditions. The effect of agitation speed, pH and surfactant concentration on the release of ART and LUM was evaluated by employing a two-level factorial experiment. The resulting final method was validated for linearity, precision, robustness and API stability. In addition, the discriminatory power of the method was evaluated using expired and unexpired FDC ART/LUM products. Results A suitable dissolution profile of FDC ART/LUM tablets was obtained in 900 ml HCl (0.025 N, pH 1.6) with 1%Myrj 52 using paddle method at 100 rpm and 37 degrees C. ART and LUM were analysed using a HPLC method with UV detection at wavelengths of 210 and 335 nm, respectively. The results from the stability study showed that ART and LUM were sufficiently stable in HCl (0.025 N, pH 1.6) with 1%Myrj 52 at 37 degrees C. The method was linear (r(2) = 0.999) over the concentration range of 6.25-100 mu g/ml. The results for precision were within the acceptance limit (%RSD < 2). The percent relative standard deviation (< 2%) and statistically non-significant (p > 0.05) difference in release of ART and LUM observed between deliberately changed dissolution method settings (pH = 1.6 +/- 0.2 or agitation speed = 100 +/- 2) and optimized dissolution conditions revealed the robustness of the dissolution method. The method was capable to discriminate among different FDC ART/LUM products with different quality. Conclusions The developed dissolution method is robust and discriminatory. It can be used in the quality evaluation of FDC ART/LUM tablets.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya
    Elizabeth A Juma
    Charles O Obonyo
    Willis S Akhwale
    Bernhards R Ogutu
    Malaria Journal, 7
  • [42] Artemether-lumefantrine for the treatment of moderate malaria in children
    Sasi, Philip
    English, Mike
    Muchohi, Simon
    Makanga, Michael
    Nzila, Alexis
    Lowe, Brett
    Kokwaro, Gilbert
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2006, 75 (05): : 208 - 208
  • [44] SUSTAINED HIGH CURE RATE OF ARTEMETHER LUMEFANTRINE IN TANZANIA
    Ngasala, Billy
    Mwaiswelo, Richard
    Martensson, Andreas
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 84 - 84
  • [45] Developmental toxicity studies of lumefantrine and artemether in rats and rabbits
    Clark, Robert L.
    Youreneff, Maureen
    DeLise, Anthony M.
    BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2016, 107 (06) : 243 - 257
  • [46] Continued Low Efficacy of Artemether-Lumefantrine in Angola?
    Rasmussen, Charlotte
    Ringwald, Pascal
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (06)
  • [47] Artemether-lumefantrine for uncomplicated malaria: a systematic review
    Omari, AA
    Gamble, C
    Garner, P
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (02) : 192 - 199
  • [48] EFFICACY OF CHLOROQUINE OR ARTEMETHER-LUMEFANTRINE AGAINST PLASMODIUM VIVAX AND ARTEMETHER-LUMEFANTRINE AGAINST UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA IN CENTRAL ETHIOPIA
    Hailegiorgis, Bereket
    Hwang, Jimee
    Melaku, Zenebe
    Girma, Samuel
    Teshi, Takele
    Gebresellasie, Sintayehu
    Demeke, Leykun
    Hoos, David
    Gobena, Kedir
    Kassa, Moges
    Jima, Daddi
    Reithinger, Richard
    Malone, Joseph
    Kachur, S. Patrick
    Filler, Scott
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 374 - 375
  • [49] A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya
    Juma, Elizabeth A.
    Obonyo, Charles O.
    Akhwale, Willis S.
    Ogutu, Bernhards R.
    MALARIA JOURNAL, 2008, 7 (1)
  • [50] A derivatization-based densitometric method for simultaneous estimation of artemether and lumefantrine: Method development, validation and applications
    Kaur, Ripandeep
    Katare, O. P.
    Singh, Guneet
    Mohan, Vishav
    Saini, Sumant
    Singh, Bhupinder
    MICROCHEMICAL JOURNAL, 2021, 171